ConductScience.org, home

Gene · 1595

Papers2,112

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

81 to 100 of 2,112

Download this page as JSON
TitleJournalYearPMIDFound bySource
Unique Structural Features Relate to Evolutionary Adaptation of Cytochrome P450 in the Abyssal Zone.Int J Mol Sci202540565153PubTator, text miningPubMed
Discovery of a potent, broad-spectrum and in vivo effective deuterated tetrazole CYP51 inhibitor.Eur J Med Chem202540472486PubTator, text miningPubMed
In Vitro Evaluation of the Healing Potential and Proteomic Study of Quercus robur L. Leaf Extracts in Human Keratinocytes.Molecules202540430324PubTator, text miningPubMed
Progress and Prospects of Triazoles in Advanced Therapies for Parasitic Diseases.Trop Med Infect Dis202540423371PubTator, text miningPubMed
Identifying prognostic targets in metastatic prostate cancer beyond AR.FEBS Open Bio202540405591PubTator, text miningPubMed
Synthesis and Biological Evaluation of Novel 1,2,4-Triazole Derivatives Containing Amino Acid Fragments.Molecules202540333687PubTator, text miningPubMed
Synthesis and Activity of Novel Pyrazole/Pyrrole Carboxamides Containing a Dinitrogen Six-Membered Heterocyclic as Succinate Dehydrogenase and Ergosterol Biosynthesis Inhibitors against Colletotrichum camelliae.
J Agric Food Chem202540266629PubTator, text miningPubMed
Identification of FLVCR1 as the iron metabolism-related gene of statin-associated diabetes.Acta Diabetol202540146399PubTator, text miningPubMed
Synthesis and Evaluating the Anticandidal Activities of Triazino[4,3-a]Quinolinecarboxylate Derivatives: A Promising Approach to Combat Candida Infections.Chem Biodivers202540100043PubTator, text miningPubMed
Azole resistance: insights from Y132 substitutions in Candida sterol 14α-demethylase utilizing molecular dynamics simulations.J Biomol Struct Dyn202540091806PubTator, text miningPubMed
Transposable elements in genomic architecture of Monilinia fungal phytopathogens and TE-driven DMI-resistance adaptation.Mob DNA202540055830PubTator, text miningPubMed
CYP51A1 drives resistance to pH-dependent cell death in pancreatic cancer.Nat Commun202540055353PubTator, text miningPubMed
Thermal proteome profiling and proteome analysis using high-definition mass spectrometry demonstrate modulation of cholesterol biosynthesis by next-generation galeterone analog VNPP433-3β in castration-resistant prostate cancer.
Mol Oncol202540007440PubTator, text miningPubMed
1,3,4-oxadiazole derivatives: synthesis, characterization, antifungal activity, DNA binding investigations, TD-DFT calculations, and molecular modelling.J Biomol Struct Dyn202539886763PubTator, text miningPubMed
Synthesis and Antifungal Activity of Fmoc-Protected 1,2,4-Triazolyl-α-Amino Acids and Their Dipeptides Against Aspergillus Species.Biomolecules202539858455PubTator, text miningPubMed
Unveiling the Broad-Spectrum Efficacy of Volatile Terpenes to Fight Against SARS-COV-2-Associated Mucormycosis.Chem Biodivers202539853998PubTator, text miningPubMed
The Significance of Mono- and Dual-Effective Agents in the Development of New Antifungal Strategies.Chem Biol Drug Des202539841631PubTator, text miningPubMed
Enhanced Resistance to Pokkah Boeng Disease in Sugarcane Through Host-Induced Gene Silencing Targeting FsCYP51 in Fusarium sacchari.Plant Cell Environ202539829218PubTator, text miningPubMed
Microwave-Assisted Synthesis of Bis-1,2,3-Triazole-Based Benzophenones, In Vitro Antimicrobial Activity, and Molecular Docking Studies.Chem Biodivers202539780475PubTator, text miningPubMed
YY2-CYP51A1 signaling suppresses hepatocellular carcinoma progression by restraining de novo cholesterol biosynthesis.Biochim Biophys Acta Mol Basis Dis202539761760PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1595/papers?page=5